Testing tumor markers to help detect early pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at “tumor regulatory molecules,” which are substances that may be released by cancer, to improve early pancreatic cancer detection. You may join if you have early, localized pancreatic cancer that can be treated with surgery, or certain pancreatic cysts/fluid collections where doctors are investigating further.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You can sign a consent form (or you have a way to understand and agree to the study).
- You must fit one of these groups: localized pancreatic cancer planned for surgery, localized pancreatic cancer that cannot be operated on and needs further care, pancreatic cysts or suspicious lesions needing further diagnostic procedures, or specific pancreatic fluid/pseudocyst or gallbladder-related conditions needing endoscopic/surgery evaluation.
- Your cancer situation should be limited to the pancreas area (localized) and treated as planned by your medical team.
- You should not have another active cancer, or a different cancer treated within the last 5 years.
- You cannot join if you have HIV or hepatitis C (or another known contagious infection).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood “markers” to find early signs or higher risk for pancreatic cancer. You may join if you have certain risk factors (like new diabetes, pancreatic cysts/pancreatitis, or a strong family history) and can come to Omaha for blood draws twice a year.
This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.
This study looks at using MRI scans to find pancreatic cancer early in people who have certain types of pancreatic cysts that may raise their risk. If you have these cysts, joining could help catch any cancer sooner, when it might be easier to treat.
This study looks at blood tests to find markers that may help detect and monitor pancreatic cancer. It compares people with pancreatic cancer to those with benign pancreatic conditions and healthy volunteers.
This study looks at “biomarkers” (test signals in tissue or blood) in people with pancreatic cancer. It may help researchers understand the disease better and find ways to predict or track it.
This study looks for people at high risk for pancreatic cancer, either because of family history, certain genetic mutations, or concerning pancreatic cysts. Researchers want to follow you over time to find cancer early, when it's easier to treat.
Hear when a new Pancreas Cyst trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.